Author(s)

Yu Gu, Dianyu Lu, Yonghua Yao, Wei Wei^*

Affiliation(s)

Department of anesthesiology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510030, China

Corresponding Author

Wei Wei

ABSTRACT

Objective: To investigate the effect of dexmedetomidine (Dex) on the expression of nuclear factor Erythroid 2-related factor 2 (Nrf2) and the activation of endoplasmic reticulum stress (ERS) in renal tissues during ischemia/reperfusion (I/R). Methods: C57BL/6 mice were selected and divided into Sham group, I/R group, Dex group and (Dex+I/R) group. Serum urea nitrogen (BUN) and creatinine (Cr) were detected, and the expressions of Nrf2, ER chaperone BiP (GRP78) and C/EBP homologous protein (CHOP) were detected by qPCR. Results: Compared with the Sham group, the serum levels of BUN and Cr were significantly elevated in I/R group, meanwhile, the expressions of Nrf2, GRP78 and CHOP in renal tissues were also significantly increased (P<0.05). Dex pretreatment significantly lowered serum levels of BUN and Cr, as well as inhibited intracellular expressions of GRP78 and CHOP, while obviously increased intracellular Nrf2 expression in renal tissues of I/R-treated mice (P<0.05). Conclusions: Dex has a protective effect on renal I/R injury, its mechanism may be related to the activation of Nrf2 expression and further inhibit the activation of ERS-related apoptotic pathways.

KEYWORDS

dexmedetomidine, ischemia/reperfusion, Nrf2, endoplasmic reticulum stress

CITE THIS PAPER

Yu Gu, Dianyu Lu, Yonghua Yao, Wei Wei. Dexmedetomidine ameliorates ischemia/reperfusion-induced acute kidney injury by inhibiting endoplasmic reticulum stress via the nrf2 signaling pathway.Acta Translational Medicine. 2021, 4(1): 15-18.

REFERENCES

1. Ueda N, Kaushal GP, Shah SV. Apoptotic mechanisms in acute renal failure. The American journal of medicine 2000, 108(5): 403-415.

2. Choi YJ, Zhou D, Barbosa ACS, Niu Y, Guan X, Xu M, Ren S, Nolin TD, Liu Y, Xie W. Activation of Constitutive Androstane Receptor Ameliorates Renal Ischemia-Reperfusion-Induced Kidney and Liver Injury. Molecular pharmacology 2018, 93(3): 239-250.

3. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney international 2004, 66(2): 486-491.

4. Kieran NE, Rabb H. Immune responses in kidney preservation and reperfusion injury. Journal of investigative medicine: the official publication of the American Federation for Clinical Research 2004, 52(5): 310-314.

5. Shi Y, Melnikov VY, Schrier RW, Edelstein CL. Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. American journal of physiology Renal physiology 2000, 279(3): F509-517.

6. Price PM, Safirstein RL, Megyesi J. The cell cycle and acute kidney injury. Kidney international 2009, 76(6): 604-613.

7. Daemen MA, van 't Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. The Journal of clinical investigation 1999, 104(5): 541-549.

8. Weerink MAS, Struys M, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clinical pharmacokinetics 2017, 56(8): 893-913.

9. Chen Z, Ding T, Ma CG. Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice. Biochemical and biophysical research communications 2017, 493(2): 1143-1150.

10. Jiang L, Li L, Shen J, Qi Z, Guo L. Effect of dexmedetomidine on lung ischemia-reperfusion injury. Molecular medicine reports 2014, 9(2): 419-426.

11. Yoshikawa Y, Hirata N, Kawaguchi R, Tokinaga Y, Yamakage M. Dexmedetomidine maintains its direct cardioprotective effect against ischemia/reperfusion injury in hypertensive hypertrophied myocardium. Anesthesia and analgesia 2018, 126(2): 443-452.

12. Li Q, Chen C, Chen X, Han M, Li J. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion. Life sciences 2018, 207: 1-8.

13. Zhang XY, Liu ZM, Wen SH, Li YS, Li Y, Yao X, Huang WQ, Liu KX. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats. Anesthesiology 2012, 116(5): 1035-1046.

14. Shu S, Zhu J, Liu Z, Tang C, Cai J, Dong Z. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease. EBioMedicine 2018, 37: 269-280.

15. Shen X, Zhang K, Kaufman RJ. The unfolded protein response--a stress signaling pathway of the endoplasmic reticulum. Journal of chemical neuroanatomy 2004, 28(1-2): 79-92.

16. Lai E, Teodoro T, Volchuk A. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology (Bethesda, Md) 2007, 22: 193-201.

17. Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxidants & redox signaling 2018, 29(17): 1727-1745.

18. Zhang R, Xu M, Wang Y, Xie F, Zhang G, Qin X. Nrf2—a promising therapeutic target for defensing against oxidative stress in stroke. Molecular neurobiology 2017, 54(8): 6006-6017.

19. Chen Y, Bian W, Xu B. Pretreatment with dexmedetomidine alleviates lung injury in a rat model of intestinal ischemia reperfusion. Molecular medicine reports 2020, 21(3): 1233-1241.